Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Quidel Corporation
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
NIH pays for 2 million Quidel QuickVue tests in a program it is conducting with the CDC to determine whether frequent self-administered testing helps reduce community transmission of SARS-CoV-2.
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.
The US agency has granted emergency use authorization to consumer COVID-19 testing products from Quidel, Abbott and BD.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Therapeutic Drug Monitoring
- Other Names / Subsidiaries
- BioHelix Corporation
- Diagnostic Hybrids, Inc.